Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
About this item
Full title
Author / Creator
Publisher
Alexandria, VA: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
Alexandria, VA: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
The stimulation of insulin secretion by glucose can be modulated by multiple nutritive, hormonal, and pharmacological inputs. Fatty acids potentiate insulin secretion through the generation of intracellular signaling molecules and through the activation of cell surface receptors. The G-protein–coupled receptor 40 (GPR40), also known as free fatty a...
Alternative Titles
Full title
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3920793
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3920793
Other Identifiers
ISSN
0149-5992
E-ISSN
1935-5548
DOI
10.2337/dcS13-2037
